IP Library Patent Application 16307544
Patent Application
App. No. 16/307,544

SUSTAINED-RELEASE PREPARATION COMPOSITION FOR ANIMALS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/307,544
Abstract

The present invention relates to a sustained-release pharmaceutical composition intended for animal use, which comprises a drug, a sugar, a wax, and a water-soluble polymer.

Claims (13)

1 - 10 . (canceled)

11 . A sustained-release composition intended for animal use, comprising (i) zonisamide, (ii) a sugar, (iii) a wax, and (iv) a water-soluble polymer, wherein

(i) the content of zonisamide is 10 wt %-90 wt %,

(ii) the sugar is one or more selected from isomalt, mannitol, lactose, sucrose, glucose, and sorbitol, and the content of the sugar is 5 wt %-90 wt %,

(iii) the wax is one or more selected from hydrogenated castor oil, hydrogenated rapeseed oil, carnauba wax, stearic acid, and sodium stearyl fumarate, and the content of the wax is 0.5 wt %-70 wt %,

(iv) the water-soluble polymer is one or more selected from gum arabic, xanthane gum, hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), and methylcellulose (MC), the content of the water-soluble polymer is 2 wt %-80 wt %, and

the animal belongs to Carnivora.

12 . The sustained-release composition of claim 11 , wherein (i) the content of the zonisamide is 15 wt %-80 wt %, (ii) the content of the sugar is 10 wt %-80 wt %, (iii) the content of the wax is 1 wt %-60 wt %, and (iv) the content of the water-soluble polymer is 4 wt %-70 wt %.

13 . The sustained-release composition of claim 11 , wherein (i) the content of the zonisamide is 20 wt %-70 wt %, (ii) the content of the sugar is 15 wt %-70 wt %, (iii) the content of the wax is 1.5 wt %-50 wt %, and (iv) the content of the water-soluble polymer is 6 wt %-60 wt %.

14 . The sustained-release composition of claim 11 , wherein the animal is dogs or cats.

15 . The sustained-release composition of claim 11 , whose formulation is a tablet.

16 . The sustained-release composition of claim 11 , wherein the sugar is isomalt.

17 . The sustained-release composition of claim 11 , wherein the water-soluble polymer is gum arabic and/or hydroxypropylcellulose (HPC).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2018
From: KURIYAMA, TERUAKI
To: DS PHARMA ANIMAL HEALTH CO., LTD.
Reel/Frame 047692/0453 →